Our Aspiration: To become a leading LatAm biotech company delivering innovative treatments to patients in oncology, hematology, rare diseases and other severe and debilitating health conditions.
Hematology is a specialty of medicine and biology
focused on studying blood and blood-forming tissues.
It involves diagnosing, treating, and preventing diseases
and disorders related to blood, such as anemia, leukemia,
lymphoma, hemophilia, and various clotting disorders. Our company's portfolio focuses in the following health conditions:
• Paroxysmal nocturnal haemoglobinuria (PNH)
• Primary chronic immune thrombocytopenia (ITP)
• Chronic Myeloid Leukaemia (CML)
• Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
• Peripheral T cell lymphoma (PTCL)
• Polycythemia vera
Rare diseases, also known as orphan diseases,
affect a relatively small number of people within a population.
In most cases, a rare disease is defined as a condition that affects
fewer than 200,000 individuals in the United States or fewer
than 1 in 2,000 individuals in the European Union. Our company's portfolio focuses in the following health conditions:
• Hereditary Angioedema (HAE)
• Fabry Disease (FD)
• • •
Oncology is a specialty of medicine that focuses
on preventing, diagnosing, and treating cancer.
It involves the study of tumors, their development,
progression, and management. Our company's portfolio focuses in the following health condition:
• Metastatic Breast Cancer
• • •
Specialty care is a specialized area of healthcare
that focuses on the treatment of complex and chronic
medical conditions. Specialty medications often treat these conditions
and require technical knowledge, monitoring, and administration. Our company's portfolio focuses in the following health condition:
• Pulmonary Arterial Hypertension (PAH)
• • •